LUXNUVIZ
Live / Allowed — Notice of allowance issued (as of 23 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 21 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99195271
- Mark type
- Stylized text
- Filed
- 21 May 2025
- Published for opposition
- 28 Oct 2025
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of immune-mediated, autoimmune, inflammatory, and respiratory diseases and disorders, as well as rare immune-mediated, autoimmune, inflammatory, and respiratory diseases and disorders; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the skin and blood; Pharmaceutical preparations for the treatment and prevention of lesions and tumors
Owner
- Principia Biopharma Inc., Morristown, NJ, US
- Principia Biopharma Inc., Morristown, NJ, US
Prosecution history
- 23 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Oct 2025 — PUBLISHED FOR OPPOSITION
- 22 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Aug 2025 — NON-FINAL ACTION E-MAILED
- 21 Aug 2025 — NON-FINAL ACTION WRITTEN
- 19 Aug 2025 — ASSIGNED TO EXAMINER
- 26 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 26 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED